THYMOSI ANew

                                                                                                                                                                                                            
Contents               
              
  • Vial: Thymosin Alpha-1, 5mg × 5
  •           
  • Ampoule: 2ml Bacteriostatic Water for Injection IP
  •         
      
Description        THYMOSI A is a potent immunomodulatory peptide formulated with Thymosin Alpha-1, a naturally occurring thymic peptide known for its critical role in regulating and enhancing immune function.

        It works by stimulating T-cell production and activity, improving immune surveillance, and enhancing the body's defense against infections, viruses, and inflammatory conditions. Thymosin Alpha-1 also supports immune system balance by modulating cytokine response and reducing excessive inflammation.

        THYMOSI A is widely utilized in immune-support protocols, recovery enhancement, and as an adjunct therapy in chronic infections, liver disorders, and immune-compromised states, helping promote faster recovery and overall physiological resilience.      
AdministrationIntramuscular (IM) or Subcutaneous (SC) injection.
Storage        
              
  • Before reconstitution: Store at room temperature, away from heat and direct sunlight.
  •           
  • After reconstitution: Refrigerate between 2–8°C.
  •         
      
Dosage        Initial: 500–1000 mcg/day. Frequency and duration may vary based on condition and response.

        Half-life: ~2–3 hours.      
Indication        THYMOSI A may be prescribed in cases of:        
              
  • Weakened immune function
  •           
  • Chronic infections and viral conditions
  •           
  • Liver disorders
  •           
  • Inflammatory diseases
  •           
  • Immune-compromised states
  •           
  • Recovery support and immune enhancement
  •         
      
Contraindications        Do not use THYMOSI A if:        
              
  • Hypersensitivity to Thymosin Alpha-1 or formulation components
  •           
  • Pregnancy and lactation
  •           
  • Autoimmune disorders (unless under strict medical supervision)
  •         
      
Special Precautions        
              
  • Use cautiously in patients with autoimmune diseases.
  •           
  • Monitor immune markers during prolonged use.
  •           
  • Not recommended without medical supervision.
  •           
  • Discontinue use if hypersensitivity or abnormal immune response occurs.
  •         
      
Adverse Drug Reactions        
              
  • Generally well tolerated
  •           
  • Common: Injection site reactions, fatigue, headache
  •           
  • Occasional: Mild fever
  •           
  • Rare: Allergic reactions
  •         
      
Disclaimer        Images displayed on the website are for representational purposes only which may differ from the actual purchased product. The company may change or alter the packaging design without notice.